Free Trial

Riverstone Credit Opportunities Income (RCOI) Competitors

RCOI vs. IBT, BVT, JZCP, BIOG, SCP, MNP, FJV, JCGI, CVCG, and ASEI

Should you be buying Riverstone Credit Opportunities Income stock or one of its competitors? The main competitors of Riverstone Credit Opportunities Income include International Biotechnology (IBT), Baronsmead Venture Trust (BVT), JZ Capital Partners (JZCP), The Biotech Growth Trust (BIOG), Schroder UK Mid Cap (SCP), Martin Currie Global Portfolio (MNP), Fidelity Japan Trust (FJV), JPMorgan China Growth & Income (JCGI), CVC Income & Growth GBP (CVCG), and Aberdeen Standard Equity Inc Trust (ASEI). These companies are all part of the "asset management" industry.

Riverstone Credit Opportunities Income vs.

International Biotechnology (LON:IBT) and Riverstone Credit Opportunities Income (LON:RCOI) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.

International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 5.3%. Riverstone Credit Opportunities Income pays an annual dividend of GBX 8 per share. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. Riverstone Credit Opportunities Income pays out 23,854.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. International Biotechnology is clearly the better dividend stock, given its higher yield and lower payout ratio.

45.2% of International Biotechnology shares are held by institutional investors. Comparatively, 66.7% of Riverstone Credit Opportunities Income shares are held by institutional investors. 4.2% of International Biotechnology shares are held by company insiders. Comparatively, 19.8% of Riverstone Credit Opportunities Income shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

International Biotechnology has a net margin of 90.66% compared to Riverstone Credit Opportunities Income's net margin of 28.84%. International Biotechnology's return on equity of 13.67% beat Riverstone Credit Opportunities Income's return on equity.

Company Net Margins Return on Equity Return on Assets
International Biotechnology90.66% 13.67% 3.57%
Riverstone Credit Opportunities Income 28.84%2.38%N/A

Riverstone Credit Opportunities Income has higher revenue and earnings than International Biotechnology. Riverstone Credit Opportunities Income is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
International Biotechnology£41.82M4.69£37.91M£104.805.21
Riverstone Credit Opportunities Income£792.62M0.00£228.58M£0.03N/A

International Biotechnology received 136 more outperform votes than Riverstone Credit Opportunities Income when rated by MarketBeat users.

CompanyUnderperformOutperform
International BiotechnologyOutperform Votes
136
77.71%
Underperform Votes
39
22.29%
Riverstone Credit Opportunities IncomeN/AN/A

In the previous week, International Biotechnology's average media sentiment score of 0.00 equaled Riverstone Credit Opportunities Income'saverage media sentiment score.

Company Overall Sentiment
International Biotechnology Neutral
Riverstone Credit Opportunities Income Neutral

Summary

International Biotechnology beats Riverstone Credit Opportunities Income on 7 of the 12 factors compared between the two stocks.

Get Riverstone Credit Opportunities Income News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCOI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCOI vs. The Competition

MetricRiverstone Credit Opportunities IncomeAsset Management IndustryFinancial SectorLON Exchange
Market Cap£49.07M£1.10B£3.69B£2.51B
Dividend Yield50.52%4.36%4.15%4.79%
P/E Ratio21.4723.5613.96130.39
Price / SalesN/A2,227.551,653.93234,760.20
Price / CashN/A60.9950.4028.28
Price / BookN/A1.103.344.42
Net Income£228.58M£261.75M£1.24B£5.89B

Riverstone Credit Opportunities Income Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCOI
Riverstone Credit Opportunities Income
N/AN/AN/AN/A£49.07M£792.62M21.47N/A
IBT
International Biotechnology
N/AGBX 542
+5.4%
N/A-10.8%£194.69M£41.82M5.17N/A
BVT
Baronsmead Venture Trust
N/AGBX 49.80
+2.0%
N/A-5.1%£193.31M£17.57M14.56N/ADividend Increase
Gap Up
JZCP
JZ Capital Partners
N/AGBX 192
-0.2%
N/A+3.9%£193.13M£21.12M119.88N/A
BIOG
The Biotech Growth Trust
N/AGBX 676
+4.6%
N/A-27.4%£193.13M£87.94M2.27N/ANews Coverage
Positive News
SCP
Schroder UK Mid Cap
N/AGBX 552
+2.2%
N/A+2.6%£190.96M£40.15M5.25N/ADividend Increase
MNP
Martin Currie Global Portfolio
N/AGBX 315
+2.6%
N/A-14.6%£189.05M£16.16M13.58N/ADividend Announcement
FJV
Fidelity Japan Trust
N/AGBX 165
+4.4%
N/A-4.3%£187.45M£8.79M29.78N/ANews Coverage
JCGI
JPMorgan China Growth & Income
N/AGBX 224
+5.9%
N/A+1.7%£187.14M£8.78M29.63N/APositive News
Gap Down
CVCG
CVC Income & Growth GBP
N/AGBX 118.50
flat
N/A+5.5%£183.62M£45.23M0.60N/A
ASEI
Aberdeen Standard Equity Inc Trust
N/AN/AN/AN/A£177.24M£56.72M3.26N/A

Related Companies and Tools


This page (LON:RCOI) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners